Richard D. Carvajal MD
Roy J. and Tara Zuckerberg Professor in Medical Oncology, Deputy Physician-in-Chief, Director of Hematology/Oncology, Northwell Health Cancer Institute, Lake Success, New YorkRichard D. Carvajal, MD, is the Roy J. and Tara Zuckerberg Professor in Medical Oncology and the Deputy Physician-in-Chief and Director of Hematology/Oncology at the Northwell Health Cancer Institute. He is recognized as a leader within the melanoma field, with particular expertise in rare melanoma subtypes such as uveal, mucosal and acral melanoma. His research has been supported by the National Cancer Institute, the Food and Drug Administration, the Conquer Cancer Foundation, the Melanoma Research Alliance, and the Melanoma Research Foundation. He has authored or co-authored more than 250 peer-reviewed manuscripts, books, and book chapters.
Disclosures
Consulting:
Alkermes, Bristol Myers Squibb, Castle Biosciences, Delcath, Eisai, Hengrui, Ideaya, Immunocore, InxMed, Iovance, Merck, Novartis, Oncosec, Pierre Fabre, PureTech Health, Regeneron, Sanofi Genzyme, Trisalus
Clinical/Scientific Advisory Boards:
Aura Biosciences, Chimeron, Rgenix